Senate committee approves 340B reform legislation
Lawmakers signed off Wednesday evening on a plan to prohibit pharmaceutical manufacturers from interfering with providers’ ability to receive prescription drugs if contracted with the 340B program.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
